Watch for Bexagliflozin, a New Med for Type 2 Diabetes
September 2023
You’ll hear buzz about new Rx bexagliflozin (Brenzavvy).
Think of it as similar to other SGLT2 inhibitors for type 2 diabetes...dapagliflozin, empagliflozin, etc.
A big difference is that bexagliflozin will cost about $50 per month...versus about $600 per month for other SGLT2 inhibitors.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote